These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 9385694)

  • 21. Suggestion of nonlinear or phasic progression of knee osteoarthritis based on measurements of serum cartilage oligomeric matrix protein levels over five years.
    Sharif M; Kirwan JR; Elson CJ; Granell R; Clarke S
    Arthritis Rheum; 2004 Aug; 50(8):2479-88. PubMed ID: 15334461
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Synovial fluid glycosaminoglycan concentration does not correlate with severity of chondropathy or predict progression of osteoarthritis in a canine cruciate deficiency model.
    Myers SL; Brandt KD; Albrecht ME
    J Rheumatol; 2000 Mar; 27(3):753-63. PubMed ID: 10743821
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunologic modulation of cartilage metabolism.
    Herman JH; Appel AM
    J Rheumatol; 1987 May; 14 Spec No():83-5. PubMed ID: 3305941
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Cartilage oligomeric matrix protein, a possible marker of synovitis in early knee joint osteoarthrosis].
    Svetlova MS; Vezikova NN; Romashina VV; Sobanina TS; Pavlov IuL; Chepliukova IA
    Klin Med (Mosk); 2008; 86(11):65-8. PubMed ID: 19177799
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Serum and synovial fluid concentrations of keratan sulfate and hyaluronan in dogs with induced stifle joint osteoarthritis following cranial cruciate ligament transection.
    Budsberg SC; Lenz ME; Thonar EJ
    Am J Vet Res; 2006 Mar; 67(3):429-32. PubMed ID: 16506904
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mechanism of cartilage destruction in osteoarthritis.
    Ishiguro N; Kojima T; Poole AR
    Nagoya J Med Sci; 2002 Nov; 65(3-4):73-84. PubMed ID: 12580533
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Inhibition of interleukin-1alpha-induced cartilage oligomeric matrix protein degradation in bovine articular cartilage by matrix metalloproteinase inhibitors: potential role for matrix metalloproteinases in the generation of cartilage oligomeric matrix protein fragments in arthritic synovial fluid.
    Ganu V; Goldberg R; Peppard J; Rediske J; Melton R; Hu SI; Wang W; Duvander C; Heinegård D
    Arthritis Rheum; 1998 Dec; 41(12):2143-51. PubMed ID: 9870871
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Treatment with calcitonin suppresses the responses of bone, cartilage, and synovium in the early stages of canine experimental osteoarthritis and significantly reduces the severity of the cartilage lesions.
    Manicourt DH; Altman RD; Williams JM; Devogelaer JP; Druetz-Van Egeren A; Lenz ME; Pietryla D; Thonar EJ
    Arthritis Rheum; 1999 Jun; 42(6):1159-67. PubMed ID: 10366108
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The effect of sonication on simulated osteoarthritis. Part II: alleviation of osteoarthritis pathogenesis by 1 MHz ultrasound with simultaneous hyaluronate injection.
    Park SR; Park SH; Jang KW; Cho HS; Cui JH; An HJ; Choi MJ; Chung SI; Min BH
    Ultrasound Med Biol; 2005 Nov; 31(11):1559-66. PubMed ID: 16286033
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Correlation between osteoarthritic cartilage damage and levels of proteinases and proteinase inhibitors in synovial fluid from the knee joint.
    Maiotti M; Monteleone G; Tarantino U; Fasciglione GF; Marini S; Coletta M
    Arthroscopy; 2000; 16(5):522-6. PubMed ID: 10882449
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Beneficial effects of intermittent fluid pressure of low physiological magnitude on cartilage and inflammation in osteoarthritis. An in vitro study.
    van Valburg AA; van Roy HL; Lafeber FP; Bijlsma JW
    J Rheumatol; 1998 Mar; 25(3):515-20. PubMed ID: 9517773
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary type II collagen helical peptide (HELIX-II) as a new biochemical marker of cartilage degradation in patients with osteoarthritis and rheumatoid arthritis.
    Charni N; Juillet F; Garnero P
    Arthritis Rheum; 2005 Apr; 52(4):1081-90. PubMed ID: 15818703
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Cell interactions in osteoarthritis: proposed role for cartilage-derived growth factor.
    Hamerman D; Klagsbrun M
    Trans Assoc Am Physicians; 1983; 96():316-23. PubMed ID: 6388103
    [No Abstract]   [Full Text] [Related]  

  • 34. The role of molecular markers to monitor disease, intervention and cartilage breakdown in osteoarthritis.
    Lohmander LS; Roos H; Dahlberg L; Lark MW
    Acta Orthop Scand Suppl; 1995 Oct; 266():84-7. PubMed ID: 8553867
    [No Abstract]   [Full Text] [Related]  

  • 35. Applications of proteomics in cartilage biology and osteoarthritis research.
    Williams A; Smith JR; Allaway D; Harris P; Liddell S; Mobasheri A
    Front Biosci (Landmark Ed); 2011 Jun; 16(7):2622-44. PubMed ID: 21622199
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synovial fluid markers in osteoarthritis.
    Myers SL
    Rheum Dis Clin North Am; 1999 May; 25(2):433-49, viii-ix. PubMed ID: 10356427
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Biomarkers in osteoarthritis].
    Durdica BN; Bozidar C
    Reumatizam; 2010; 57(1):5-9. PubMed ID: 20941933
    [No Abstract]   [Full Text] [Related]  

  • 38. Inflammation in osteoarthritis.
    Altman RD; Gray R
    Clin Rheum Dis; 1985 Aug; 11(2):353-65. PubMed ID: 2994947
    [No Abstract]   [Full Text] [Related]  

  • 39. Markers of osteoarthritis and cartilage research in animal models.
    Malemud CJ
    Curr Opin Rheumatol; 1993 Jul; 5(4):494-502. PubMed ID: 8251023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cartilage and osteoarthritis: current concepts.
    Moskowitz RW
    J Rheumatol; 1977; 4(4):329-31. PubMed ID: 604471
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.